Heart drug fails to help patients off life support in terminated trial
NCT ID NCT04158674
First seen Feb 03, 2026 · Last updated May 12, 2026 · Updated 10 times
Summary
This study tested whether the drug levosimendan could help people with severe heart failure safely come off a heart-lung machine (ECLS). The trial planned to include 82 adults who were ready to try weaning off the machine. However, the study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Dijon Bourgogne
Dijon, 21079, France
Conditions
Explore the condition pages connected to this study.